Versant Venture Management, LLC Portfolio Holdings

Versant Venture Management, LLC

  • $38.2 Million
  • Q3 2024

Versant Venture Management, LLC has filed its 13F form on November 08, 2024 for Q3 2024 where it was disclosed a total value porftolio of $38.2 Million distributed in 6 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Crispr Therapeutics Ag with a value of $23.4M, Repare Therapeutics Inc. with a value of $9.1M, Adverum Biotechnologies, Inc. with a value of $3.56M, Gritstone Bio, Inc. with a value of $2.07M, and Contineum Therapeutics, Inc. with a value of $0.

Examining the 13F form we can see an decrease of $6.88M in the current position value, from $45M to 38.2M.

Versant Venture Management, LLC is based out at San Francisco, CA

Below you can find more details about Versant Venture Management, LLC portfolio as well as his latest detailed transactions.

Portfolio value $38.2 Million
Healthcare: $38.2 Million

Stock Holdings Table Market Cap. of Under $50 Millions

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History
$2.19M
$2.07 Million 5.41% of portfolio
3,561,150
Q4 2021 Reduced 11.1%

Summary

  • Portfolio
  • No. of Stocks 6
  • Current Value $38.2 Million
  • Prior Value $45 Million
  • Filing
  • Period Q3 2024
  • Filing Date November 08, 2024
  • Form Type 13F-HR
  • Activity in Q3 2024
  • New Purchases 0 stocks
  • Additional Purchases 0 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 0 stocks
Track This Portfolio

Track Versant Venture Management, LLC Portfolio

Follow Versant Venture Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Versant Venture Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Versant Venture Management, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email